Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy (all authors).
Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy (all authors)..
J Minim Invasive Gynecol. 2021 Aug;28(8):1519-1525. doi: 10.1016/j.jmig.2020.12.026. Epub 2020 Dec 26.
There are growing concerns regarding the potential risk of coronavirus disease transmission during surgery and in particular during minimally invasive procedures owing to the aerosolization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles. However, no study has demonstrated this hypothesis. Here, we aimed to investigate the presence of SARS-CoV-2 in surgical smoke.
A prospective pilot study.
A tertiary cancer center in northern Italy.
Overall, 17 patients underwent laparoscopic procedures for the management of suspected or documented gynecologic malignancies. The median age was 57 years (range 26-77). The surgical indications included endometrial cancer (n = 11), borderline ovarian tumor (n = 3), early-stage ovarian cancer (n = 1), stage IA cervical cancer after diagnostic conization (n = 1), and an ovarian cyst that turned out to be benign at final histologic examination (n = 1).
We evaluated all consecutive women scheduled to have laparoscopic procedures for suspected or documented gynecologic cancers. The patients underwent planned laparoscopic surgery. At the end of the laparoscopic procedures (after extubation), we performed reverse transcription-polymerase chain reaction (RT-PCR) tests for the detection of SARS-CoV-2 from both the endotracheal tube and the filter applied on the trocar valve.
In 1 patient, both swab tests (endotracheal tube and trocar valve filter) showed amplification of the N gene on RT-PCR analysis. This case was considered to be a presumptive positive case. In another case, the RT-PCR analysis showed an amplification curve for the N gene only in the swab test performed on the filter. No ORF1ab amplification was detected.
Our study suggested the proof of principle that SARS-CoV-2 might be transmitted through surgical smoke and aerosolized native fluid from the abdominal cavity.
由于严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)颗粒的气溶胶化,人们越来越担心冠状病毒病在手术中、特别是在微创手术期间传播的潜在风险。然而,尚无研究证明这一假设。在这里,我们旨在调查手术烟雾中是否存在 SARS-CoV-2。
一项前瞻性试点研究。
意大利北部的一家三级癌症中心。
共有 17 名患者因疑似或确诊的妇科恶性肿瘤接受了腹腔镜手术。中位年龄为 57 岁(范围 26-77 岁)。手术指征包括子宫内膜癌(n=11)、交界性卵巢肿瘤(n=3)、早期卵巢癌(n=1)、诊断性宫颈锥切术后的 IA 期宫颈癌(n=1)和卵巢囊肿,最终组织学检查为良性(n=1)。
我们评估了所有计划行腹腔镜手术治疗疑似或确诊妇科癌症的连续女性患者。患者接受了计划中的腹腔镜手术。在腹腔镜手术结束时(拔管后),我们对气管内导管和应用于套管阀的过滤器进行了逆转录-聚合酶链反应(RT-PCR)检测,以检测 SARS-CoV-2。
在 1 名患者中,两种拭子检测(气管内导管和套管阀过滤器)均显示 RT-PCR 分析中 N 基因的扩增。该病例被认为是推定阳性病例。在另一个病例中,仅在过滤器上进行的拭子检测的 RT-PCR 分析显示 N 基因的扩增曲线。未检测到 ORF1ab 扩增。
我们的研究表明,SARS-CoV-2 可能通过手术烟雾和来自腹腔的气溶胶化天然液体传播的原理得到了证明。